Screener
Guardant Health GH EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Guardant Health’s reported figures.
The source filing: Guardant Health’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:16 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001576280-26-000026
FAQ
- What is Guardant Health's EBITDA?
- Guardant Health (GH) reported EBITDA of -$111.91M in Q1 2026.
- How has Guardant Health's EBITDA changed year-over-year?
- Guardant Health's EBITDA decreased by 11.0% year-over-year, from -$100.81M to -$111.91M.
- What is the long-term trend for Guardant Health's EBITDA?
- Over 4 years (2021 to 2025), Guardant Health's EBITDA has grown at a 0.6% compound annual growth rate (CAGR), from -$388.73M to -$397.51M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Guardant Health's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude